相关实验视频

Updated: Jun 29, 2025

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

瘤微环境对不同乳腺癌亚型和应用疗法的影响

Cristina Ferreira Almeida¹, Georgina Correia-da-Silva¹, Natércia Teixeira¹

¹UCIBIO, Laboratory of Biochemistry, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.

Biochemical pharmacology

|April 1, 2024

概括

需要针对瘤微环境 (TME) 的新型乳腺癌疗法. 了解TME组件为克服治疗耐药性和改善患者结果提供了新的策略.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
免疫学免疫学免疫学

背景情况:

尽管治疗方面取得了进展,乳腺癌发病率和死亡率仍然很高.
针对细胞增殖 (例如,CDK4/6抑制剂) 对特定亚型有希望.
现有的疗法往往忽略了瘤微环境 (TME).

研究的目的:

审查目前针对不同亚型的乳腺癌治疗方法.
探索TME在乳腺癌发展和进展中的作用.
突出TME作为新治疗目标的来源.

主要方法:

对现有的乳腺癌治疗方法的文献综述.
对TME的细胞和非细胞组成部分的分析.
检查TME对治疗反应和耐药性的影响.

主要成果:

跨乳腺癌亚型的TME成分各不相同,影响预后.
TME积极影响瘤生长,转移和治疗反应.
TME相互作用可能导致治疗失败,复发和耐药性.

结论:

在塑造乳腺癌的行为和治疗结果方面,TME至关重要.
准TME为开发下一代癌症治疗提供了一个有希望的途径.
对TME组件的进一步研究可以产生新的治疗策略来对抗乳腺癌.

关键词:

乳腺癌乳腺癌乳腺癌抗癌疗法是一种抗癌治疗.激素受体激素受体激素受体激素激素激素激素激素瘤微环境是一个微环境.

更多相关视频

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System

Analyzing the Communication Between Monocytes and Primary Breast Cancer Cells in an Extracellular Matrix Extract ECME-based Three-dimensional System

Published on: January 8, 2018

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...